Streetbeat News

Revenues

CSR

Center (NYSE:CSR), a real estate investment trust (REIT), has been analyzed by 4 analysts revealing a mix of bullish and indifferent sentiments with no bearish views. The average 12-month price target for CSR is $63.25, up from $62.00, with targets ranging from $59.00 to $68.00. Recent analyst actions include ratings adjustments and price target changes by RBC Capital and Baird, reflecting updated market conditions and company performance. Despite a market cap below industry average and a revenue decline of -4.99% as of March 31, 2024, Center's net margin and ROE outperform industry averages, while its ROA and debt management indicate areas for improvement.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 6:00 pm

ECLN

EMLP

PPL

PPL Corporation (NYSE:PPL) exceeded Q1 FY24 revenue and EPS estimates with significant growth in electricity sales and operating income. The company is on track with its $3 billion infrastructure improvements for the year, aiming for a modern, resilient grid and sustainable energy future. PPL reiterated its FY24 EPS outlook and its long-term growth targets, including annual savings from operational efficiencies. Shares rose 2.09% following the announcement. Exposure to PPL can also be gained through ECLN and EMLP ETFs.

Portfolio Pulse from Lekha Gupta

May 01, 2024 | 5:16 pm

AMD

DIA

NVDA

QQQ

SPY

US stocks showed mixed performance ahead of the Federal Reserve meeting, with the S&P 500 and Nasdaq 100 experiencing slight declines, while the Dow Jones saw gains. Advanced Micro Devices (AMD) reported less optimistic Q2 guidance, causing its shares and those of Nvidia (NVDA) to fall. The ADP report indicated strong private job additions, but the ISM Manufacturing Index fell into contraction. Bitcoin also saw a significant drop. Various companies reacted to earnings reports, influencing their stock prices.

Portfolio Pulse from Piero Cingari

May 01, 2024 | 5:07 pm

DLTR

Dollar Tree (NASDAQ:DLTR) received mixed analyst ratings with a shift towards a more bullish sentiment over the past 30 days. The average 12-month price target is set at $156.5, with a high of $180.00 and a low of $140.00, marking a slight decline from the previous average of $158.54. The company's financials show a positive revenue trend with an 11.91% growth rate, but it struggles with below-industry net margin and ROE. Dollar Tree operates over 16,750 stores in the U.S. and Canada, with a significant portion of sales from consumables.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 5:01 pm

GEHC

GE HealthCare Techs (NASDAQ:GEHC) received mixed analyst ratings with a majority being bullish. The average 12-month price target is $99.78, marking a 13.88% increase from the previous target. Analysts from firms like Mizuho, Evercore ISI Group, Citigroup, Argus Research, HSBC, Morgan Stanley, and UBS have adjusted their ratings and price targets, reflecting various market conditions and company performance. GE HealthCare Techs, a leader in medical technology and diagnostics, shows solid revenue growth but faces challenges in net margin, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 5:00 pm

NBIX

Neurocrine Biosciences (NASDAQ:NBIX) received mixed analyst ratings with an updated average 12-month price target of $158.91, reflecting a 6.29% increase from the previous target. Analyst actions varied, with some raising, maintaining, or lowering their ratings and price targets. The company's financials show a solid revenue growth rate of 25.05% but below industry benchmarks in market capitalization, net margin, ROE, and ROA, indicating potential challenges.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 5:00 pm

VIST

Vista Energy (NYSE:VIST) received mixed analyst ratings in the last quarter, with a shift towards a neutral stance in the past 30 days. Analysts have updated their 12-month price targets, setting an average of $50.00, up from the previous $45.67. The company, operating in Argentina and Mexico, showed a revenue growth of 0.05% as of March 31, 2024, but faces challenges with below-average net margin, ROE, ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 5:00 pm

KAI

Four analysts have recently updated their ratings on Kadant (NYSE:KAI), all maintaining a somewhat bullish stance with an average 12-month price target of $345.00, marking a 1.47% increase from the previous target of $340.00. Kadant, a supplier in papermaking, recycling, and related industries, has shown a revenue growth of 2.83% and a net margin of 11.48%, outperforming industry standards. Despite its market capitalization being below the industry average, its financial health is strong, with exceptional ROE and ROA figures, and a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 5:00 pm

SILK

Silk Road Medical (NASDAQ:SILK) received mixed ratings from 6 analysts, with a shift towards a neutral stance in the last 30 days. The average 12-month price target was raised to $20.83, indicating a 33.53% increase from the previous target. The company, focusing on reducing stroke risks through its TCAR procedure, shows a revenue growth of 17.97% but struggles with profitability, having a net margin of -27.52%. Its financial strength is noted with an exceptional ROE of -8.55% and a conservative debt management with a debt-to-equity ratio of 0.51.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 5:00 pm

HMC

American Honda reported total sales of 116,586 units for April, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 4:01 pm